Literature DB >> 11414686

The glucuronyl C5-epimerase activity is the limiting factor in the dermatan sulfate biosynthesis.

K Tiedemann1, T Larsson, D Heinegård, A Malmström.   

Abstract

An early step in the biosynthesis of dermatan sulfate is polymerization to chondroitin, which then is modified by the D-glucuronyl C5-epimerase and mainly 4-O-sulfotransferase. The final structure of the dermatan sulfate side chains varies and our aim was to identify, which of the two enzymes that are crucial to generate dermatan sulfate copolymeric structures in tissues. Dermatan sulfate side chains of biglycan and decorin were prepared from fibroblasts and nasal and articular chondrocytes and characterized regarding detailed structure. Microsomes were prepared from these cells and the activities of D-glucuronyl C5-epimerase and 4-O-sulfotransferase were determined. Chondrocytes from nasal cartilage synthesized biglycan and decorin containing 10%, articular chondrocytes 20--30%, and fibroblast 80% of the uronosyl residues in the l-iduronyl configuration. All three tissues contained high amount of 4-O-sulfotransferase activity. The activity of d-glucuronyl C5-epimerase showed different relationships. Fibroblasts contained a high level of the epimerase activity, articular chondrocytes intermediary activity, and in nasal cartilage it was barely detectable. The data indicate that the activity of the d-glucuronyl C5-epimerase is the main factor for formation of dermatan sulfate in tissues. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414686     DOI: 10.1006/abbi.2001.2376

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding.

Authors:  J Nigro; M L Ballinger; R J Dilley; G L R Jennings; T N Wight; P J Little
Journal:  Diabetologia       Date:  2004-12-09       Impact factor: 10.122

2.  A tandem mass spectrometric approach to determination of chondroitin/dermatan sulfate oligosaccharide glycoforms.

Authors:  May Joy C Miller; Catherine E Costello; Anders Malmström; Joseph Zaia
Journal:  Glycobiology       Date:  2006-02-17       Impact factor: 4.313

3.  Dermatan sulfate epimerase 1-deficient mice have reduced content and changed distribution of iduronic acids in dermatan sulfate and an altered collagen structure in skin.

Authors:  Marco Maccarana; Sebastian Kalamajski; Mads Kongsgaard; S Peter Magnusson; Ake Oldberg; Anders Malmström
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

4.  LC-MS and LC-MS/MS studies of incorporation of 34SO3 into glycosaminoglycan chains by sulfotransferases.

Authors:  Xiaofeng Shi; Chun Shao; Yang Mao; Yu Huang; Zhengliang L Wu; Joseph Zaia
Journal:  Glycobiology       Date:  2013-05-21       Impact factor: 4.313

5.  Glycoform quantification of chondroitin/dermatan sulfate using a liquid chromatography-tandem mass spectrometry platform.

Authors:  Alicia M Hitchcock; Catherine E Costello; Joseph Zaia
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

6.  Comparative glycomics of connective tissue glycosaminoglycans.

Authors:  Alicia M Hitchcock; Karen E Yates; Catherine E Costello; Joseph Zaia
Journal:  Proteomics       Date:  2008-04       Impact factor: 3.984

7.  Differential gene expression in skin RNA of horses affected with degenerative suspensory ligament desmitis.

Authors:  Abigail Haythorn; Madeline Young; James Stanton; Jian Zhang; P O E Mueller; Jaroslava Halper
Journal:  J Orthop Surg Res       Date:  2020-10-07       Impact factor: 2.359

8.  Does BMP2 play a role in the pathogenesis of equine degenerative suspensory ligament desmitis?

Authors:  Madeline Young; Olaniyi Moshood; Jian Zhang; Carolyn A Sarbacher; P O Eric Mueller; Jaroslava Halper
Journal:  BMC Res Notes       Date:  2018-09-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.